Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Alzheimers Dement. 2023 May 19;19(12):5387–5398. doi: 10.1002/alz.13125

Figure 5. Participant survey results for initial study visit.

Figure 5.

Responses were on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). SEABIRD participants generally reported a positive study experience and positive attitudes toward the AD blood test.